Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
SAGE Therapeutics (SAGE)
NASDAQ:SAGE
SAGE Therapeutics (SAGE) Ownership - Who Owns SAGE Therapeutics?
822 Followers
SAGE Therapeutics (SAGE) Ownership Overview
The ownership structure of SAGE Therapeutics (SAGE) stock is a mix of institutional, retail and individual investors. Approximately 84.44% of the company’s stock is owned by Institutional Investors, 7.74% is owned by Insiders and 7.81% is owned by Public Companies and Individual Investors.
7.74% Insiders
37.61% Mutual Funds
46.83% Other Institutional Investors
7.81% Public Companies and
Individual Investors
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 11, 2023 | Barrett Elizabeth Director | Bought | $37260 |
| May 11, 2023 | Barrett Elizabeth Director | Bought | $50500 |
| Mar 17, 2023 | Kimi Iguchi Cfo & Treasurer | Bought | $4080 |
| Feb 23, 2023 | Kimi Iguchi Cfo & Treasurer | Bought | $1360 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Bought | $880824 | |
| Sep 30, 2023 | Bought | $1400160 | |
| Sep 30, 2023 | Bought | $1849113 | |
| Sep 30, 2023 | Sold | $8224159 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,788,213.00 | Institution | 7.98% | 93,753,210.54 | |
| 4,372,582.00 | Institution | 7.29% | 85,615,155.56 | |
| 4,270,791.00 | Institution | 7.12% | 83,622,087.78 | |
| 3,793,792.00 | Institution | 6.33% | 74,282,447.36 | |
| 3,010,218.00 | Institution | 5.02% | 58,940,068.44 | |
| 2,448,171.00 | Institution | 4.08% | 47,935,188.18 | |
| 2,124,699.00 | Insider | 3.54% | 41,601,606.42 | |
| 1,232,649.00 | Insider | 2.06% | 24,135,267.42 | |
| 1,047,334.00 | Institution | 1.75% | 20,506,799.72 | |
| 983,301.00 | Institution | 1.64% | 19,253,033.58 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,372,582.00 | Institution | 7.29% | 85,615,155.56 | |
| 4,270,791.00 | Institution | 7.12% | 83,622,087.78 | |
| 3,010,218.00 | Institution | 5.02% | 58,940,068.44 | |
| 1,047,334.00 | Institution | 1.75% | 20,506,799.72 | |
| 983,301.00 | Institution | 1.64% | 19,253,033.58 | |
| 827,452.00 | Institution | 1.38% | 16,201,510.16 | |
| 619,369.00 | Institution | 1.03% | 12,127,245.02 | |
| 509,907.00 | Institution | 0.85% | 9,983,979.06 | |
| 502,965.00 | Institution | 0.84% | 9,848,054.70 | |
| 478,803.00 | Institution | 0.80% | 9,374,962.74 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,740,065.00 | Institution | 6.24% | 72,071,052.55 | |
| 1,591,020.00 | Institution | 2.65% | 29,799,805.00 | |
| 1,315,693.00 | Institution | 2.19% | 24,642,930.00 | |
| 1,264,154.00 | Institution | 2.11% | 24,625,719.92 | |
| 748,004.00 | Institution | 1.25% | 14,010,115.00 | |
| 731,710.00 | Institution | 1.22% | 13,704,928.00 | |
| 429,119.00 | Institution | 0.72% | 8,359,238.12 | |
| 355,051.00 | Institution | 0.59% | 6,916,393.48 | |
| 237,137.00 | Institution | 0.40% | 4,569,629.99 | |
| 200,564.00 | Institution | 0.33% | 3,864,868.28 |
FAQ
Who Owns SAGE Therapeutics (SAGE)?
According to the latest TipRanks data, approximately 46.83% of the company's stock is held by institutional investors, 7.74% is held by insiders, and 7.81% is held by retail investors.
What percentage of SAGE Therapeutics (SAGE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 46.83% of SAGE Therapeutics (SAGE) stock is held by institutional investors.
What percentage of SAGE Therapeutics (SAGE) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.81% of SAGE Therapeutics (SAGE) stock is held by retail investors.
Who owns the most shares of SAGE Therapeutics (SAGE)?
Vanguard owns the most shares of SAGE Therapeutics (SAGE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.